US Physical Therapy (USPH) closed at $97.20 on November 5, 2026, up 9.0% from the previous close, on volume of 296,462 shares (30-day average 169,688).
Data as of November 5, 2026.
5-Nov-2026
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Thu, 5-Nov 6:10 PM ET)
U.S. Physical Therapy declares $0.46 dividend
Seeking Alpha News (Thu, 5-Nov 11:54 AM ET)
U.S. Physical Therapy GAAP EPS of -$1.04 misses by $1.74, revenue of $223M beats by $8.46M
Seeking Alpha News (Wed, 4-Nov 5:16 PM ET)
USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit
Business Wire (Wed, 4-Nov 4:23 PM ET)
U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates
Business Wire (Wed, 21-Oct 7:30 AM ET)
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
Business Wire (Mon, 21-Sep 7:30 AM ET)
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
Business Wire (Thu, 27-Aug 7:30 AM ET)
U.S. Physical Therapy Announces CFO
Business Wire (Fri, 14-Aug 7:30 AM ET)
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
US Physical Therapy trades on the NYSE stock market under the symbol USPH.
As of November 5, 2026, USPH stock price climbed to $97.20 with 296,462 million shares trading.
USPH has a beta of 0.22, meaning it tends to be less sensitive to market movements. USPH has a correlation of 0.01 to the broad based SPY ETF.
USPH has a market cap of $1.45 billion. This is considered a Small Cap stock.
Last quarter US Physical Therapy reported $223 million in Revenue and $.80 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.07.
In the last 3 years, USPH traded as high as $113.63 and as low as $58.19.
The top ETF exchange traded funds that USPH belongs to (by Net Assets): IJR, SMIG, VTI, IWM, VXF.
USPH has outperformed the market in the last year with a price return of +13.8% while the SPY ETF gained +9.7%. USPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +28.7% and +12.7%, respectively, while the SPY returned -4.7% and -5.2%, respectively.
USPH support price is $87.26 and resistance is $91.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USPH shares will trade within this expected range on the day.
